| 6MAU: reference: Lead optimization and efficacy evaluation of quinazoline-based BET family inhibitors for potential treatment of cancer and inflammatory diseases., Yang SM, Yoshioka M, Strovel JW, Urban DJ, Hu X, Hall MD, Jadhav A, Maloney DJ, Bioorg Med Chem Lett. 2019 Mar 12. pii: S0960-894X(19)30143-X. doi:, 10.1016/j.bmcl.2019.03.014. PMID: 30905542 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).